Caralluma fimbriata standardized extract.
Brand name products often contain multiple ingredients. To read detailed information about each ingredient, click on the link for the individual ingredient shown above.
This is a "branded ingredient." This means that it is an ingredient used in other companies' products. For example, this product might be just one ingredient used in another company's product that contains multiple ingredients. These branded ingredients usually are not available for sale as stand alone products for consumers.
This product has been studied in clinical research. Based on this research, this product's Effectiveness Rating is:
POSSIBLY EFFECTIVEBelow is general information about the effectiveness of the known ingredients contained in the product Slimaluma. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
INSUFFICIENT RELIABLE EVIDENCE to RATE
Below is general information about the safety of the known ingredients contained in the product Slimaluma. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
LIKELY SAFE ...when used orally in amounts commonly found in foods. A hydroethanolic extract of Caralluma has Generally Recognized as Safe (GRAS) status in the US (94084).
POSSIBLY SAFE ...when used orally in medicinal amounts, short-term. Caralluma extract 500 mg twice daily has been used with apparent safety for up to 12 weeks (15272,94080,99999). The maximum recommended adult dose is 1000 mg daily (94081).
PREGNANCY AND LACTATION:
Insufficient reliable information available; avoid using.
Below is general information about the interactions of the known ingredients contained in the product Slimaluma. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
Below is general information about the adverse effects of the known ingredients contained in the product Slimaluma. Some ingredients may not be listed. This information does NOT represent a recommendation for or a test of this specific product as a whole.
General
...Orally, caralluma seems to be generally well tolerated.
Most Common Adverse Effects:
Orally: Abdominal distention, constipation, flatulence, and gastritis in the first 2 weeks of use.
Cardiovascular ...Orally, in one clinical trial, one patient with a history of hypertension receiving caralluma extract 500 mg twice daily experienced a transient increase in blood pressure. However, it subsided, and the subject remained on the extract without reappearance of the adverse event (94080).
Dermatologic ...Orally, caralluma extract use has been associated with the development of a mild skin rash in one person (99999).
Gastrointestinal ...Orally, in clinical trials, side effects have included gastrointestinal upset, abdominal distention, flatulence, constipation, and gastritis. These side effects appeared to subside within the first two weeks of use and have also been reported in patients taking placebo (15272,99999).
